| SC 13D/A | 2022-04-26 | PERCEPTIVE ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 5,333,532 | 10.0% | EDGAR |
| SC 13D/A | 2022-04-21 | PERCEPTIVE ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 5,333,532 | 10.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Deep Track Capital, LP | Crinetics Pharmaceuticals, Inc. | 1,900,000 | 4.0% | EDGAR |
| SC 13G/A | 2022-02-11 | ORBIMED ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 2,710,710 | 5.7% | EDGAR |
| SC 13G/A | 2022-02-11 | Versant Venture Capital V, L.P. | Crinetics Pharmaceuticals, Inc. | 360,028 | 0.8% | EDGAR |
| SC 13G/A | 2022-02-11 | Vivo Capital VIII, LLC | Crinetics Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-10 | Struthers Richard Scott | Crinetics Pharmaceuticals, Inc. | 1,978,334 | 4.2% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Crinetics Pharmaceuticals, Inc. | 3,276,170 | 6.9% | EDGAR |
| SC 13G/A | 2022-01-10 | FMR LLC | Crinetics Pharmaceuticals, Inc. | 3,722,294 | 7.8% | EDGAR |
| SC 13G | 2022-01-10 | DRIEHAUS CAPITAL MANAGEMENT LLC | Crinetics Pharmaceuticals, Inc. | 4,793,638 | 10.1% | EDGAR |
| SC 13G | 2021-10-29 | BIOTECHNOLOGY VALUE FUND L P | Crinetics Pharmaceuticals, Inc. | 1,600,576 | 3.5% | EDGAR |
| SC 13G | 2021-04-22 | Deep Track Capital, LP | Crinetics Pharmaceuticals, Inc. | 1,898,666 | 5.0% | EDGAR |
| SC 13G/A | 2021-02-16 | 5AM Ventures IV, L.P. | Crinetics Pharmaceuticals, Inc. | 1,307,797 | 4.0% | EDGAR |
| SC 13G/A | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | Crinetics Pharmaceuticals, Inc. | 564,102 | 1.7% | EDGAR |
| SC 13G/A | 2021-02-16 | Versant Venture Capital V, L.P. | Crinetics Pharmaceuticals, Inc. | 1,781,952 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-12 | ORBIMED ADVISORS LLC | Crinetics Pharmaceuticals, Inc. | 0 | 8.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Vivo Capital VIII, LLC | Crinetics Pharmaceuticals, Inc. | 1,819,600 | 5.5% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Crinetics Pharmaceuticals, Inc. | 4,938,349 | 15.0% | EDGAR |
| SC 13G/A | 2021-02-05 | Struthers Richard Scott | Crinetics Pharmaceuticals, Inc. | 1,703,995 | 5.1% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Crinetics Pharmaceuticals, Inc. | 2,113,195 | 6.4% | EDGAR |